Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Microbiol
Päätekijät:	Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2002
Aiheet:	Virology
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120267/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11880402/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.3.837-845.2002
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!